Skip to main content

Type 2 Diabetes

News
05/06/2025
Riya Gandhi, MA
Patients on GLP-1RAs show lower colorectal cancer rates and higher colonoscopy use, pointing to a possible dual role in prevention and early detection.
Patients on GLP-1RAs show lower colorectal cancer rates and higher colonoscopy use, pointing to a possible dual role in prevention and early detection.
Patients on GLP-1RAs show lower...
05/06/2025
Gastroenterology
News
04/22/2025
Hannah Musick
An expansive study of veterans found that serious mental illness and exposure to certain psychiatric medications significantly increase the risk of type 2 diabetes, with implications for tailored monitoring and treatment strategies.
An expansive study of veterans found that serious mental illness and exposure to certain psychiatric medications significantly increase the risk of type 2 diabetes, with implications for tailored monitoring and treatment strategies.
An expansive study of veterans...
04/22/2025
Veterans Health Today
Conference Coverage
04/02/2025
Hannah Musick
High-risk patients with diabetes who adhere to glucagon-like peptide-1 receptor agonists (GLP-1 RA) therapy experience a significant reduction in comorbidity burden, according to a large real-world study.
High-risk patients with diabetes who adhere to glucagon-like peptide-1 receptor agonists (GLP-1 RA) therapy experience a significant reduction in comorbidity burden, according to a large real-world study.
High-risk patients with diabetes...
04/02/2025
First Report Managed Care
Diabetes Watch
01/26/2022
Yvette C. Terrie, BS Pharm, RPh
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author...
01/26/2022
Podiatry Today
News
12/20/2021
Jolynn Tumolo
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
11/24/2021
Jolynn Tumolo
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care
News
03/05/2015
Dentists may be able to screen patients for diabetes while cleaning their teeth, a small study suggests. Researchers found that testing for diabetes using blood that appears on the gums during a routine oral cleaning might be just as...
Dentists may be able to screen patients for diabetes while cleaning their teeth, a small study suggests. Researchers found that testing for diabetes using blood that appears on the gums during a routine oral cleaning might be just as...
Dentists may be able to screen...
03/05/2015
First Report Managed Care
News
05/06/2025
Riya Gandhi, MA
Patients on GLP-1RAs show lower colorectal cancer rates and higher colonoscopy use, pointing to a possible dual role in prevention and early detection.
Patients on GLP-1RAs show lower colorectal cancer rates and higher colonoscopy use, pointing to a possible dual role in prevention and early detection.
Patients on GLP-1RAs show lower...
05/06/2025
Gastroenterology
News
05/06/2025
Allison Casey
According to a single arm, phase 2 study, using patient-derived organoids-based testing has potential in guiding neoadjuvant therapy among patients with locally advanced thyroid cancer.
According to a single arm, phase 2 study, using patient-derived organoids-based testing has potential in guiding neoadjuvant therapy among patients with locally advanced thyroid cancer.
According to a single arm, phase...
05/06/2025
Oncology
cole
SAWC Spring
04/28/2025
Ashton L. Stahl
How does the microcirculatory response differ between the feet of patients with and without diabetes? A poster recently presented at the Symposium for Advanced Wound Care provides an update on this knowledge.
How does the microcirculatory response differ between the feet of patients with and without diabetes? A poster recently presented at the Symposium for Advanced Wound Care provides an update on this knowledge.
How does the microcirculatory...
04/28/2025
Podiatry Today
News
04/22/2025
Hannah Musick
An expansive study of veterans found that serious mental illness and exposure to certain psychiatric medications significantly increase the risk of type 2 diabetes, with implications for tailored monitoring and treatment strategies.
An expansive study of veterans found that serious mental illness and exposure to certain psychiatric medications significantly increase the risk of type 2 diabetes, with implications for tailored monitoring and treatment strategies.
An expansive study of veterans...
04/22/2025
Veterans Health Today
Conference Coverage
04/02/2025
Hannah Musick
High-risk patients with diabetes who adhere to glucagon-like peptide-1 receptor agonists (GLP-1 RA) therapy experience a significant reduction in comorbidity burden, according to a large real-world study.
High-risk patients with diabetes who adhere to glucagon-like peptide-1 receptor agonists (GLP-1 RA) therapy experience a significant reduction in comorbidity burden, according to a large real-world study.
High-risk patients with diabetes...
04/02/2025
First Report Managed Care
News
06/28/2023
Amanda Balbi
The FDA approved the new treatment based on positive results from 2 clinical trials that included 30 participants followed for more than 5 years.
The FDA approved the new treatment based on positive results from 2 clinical trials that included 30 participants followed for more than 5 years.
The FDA approved the new...
06/28/2023
Endocrinology & Diabetes
News
03/02/2023
Jolynn Tumolo
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
01/04/2023
Jolynn Tumolo
Providers should consider using measures such as trabecular bone score in addition to bone mineral density to understand the impact of diabetes on bone microarchitecture, researchers said.
Providers should consider using measures such as trabecular bone score in addition to bone mineral density to understand the impact of diabetes on bone microarchitecture, researchers said.
Providers should consider using...
01/04/2023
Annals of Long-Term Care
News
01/03/2023
Maria Asimopoulos
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the...
01/03/2023
Pharmacy Learning Network
News
01/02/2023
Priyam Vora
New studies identify individuals 50 years of age and older and with new-onset diabetes as a high-risk group for early pancreatic cancer and call for early screenings for timely detection.
New studies identify individuals 50 years of age and older and with new-onset diabetes as a high-risk group for early pancreatic cancer and call for early screenings for timely detection.
New studies identify individuals...
01/02/2023
Gastroenterology